Non-steroidal anti-inflammatory drugs and bladder cancer prevention

British Journal of Cancer

Volumn 82, Issue 7, 2000, Pages 1364-1369

  Castelao, J E ^a   Yuan, J M ^a   Gago Dominguez, M ^a   Yu, M C ^a   Ross, R K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acetaminophen; Analgesics; Aspirin; Bladder cancer; Other NSAID drugs; Phenacetin

Indexed keywords

ACETIC ACID DERIVATIVE; ACETYLSALICYLIC ACID; IBUPROFEN; INDOMETACIN; MECLOFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PARACETAMOL; PHENACETIN; PYRAZOLONE DERIVATIVE; SALICYLIC ACID DERIVATIVE; SULINDAC;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

EID: 0034112881     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1106     Document Type: Article

References (50)

1. Angervall L, Bengtsson U, Zetterlund CG and Zsigmond M (1969) Renal pelvic carcinoma in a Swedish district with abuse of a phenacetin-containing drug. Br J Urol 41: 401-405
2. Bernstein L and Ross RK (1991) Cancer in Los Angeles County. A Portrait of Incidence and Mortality 1972-1987. University of Southern California: Los Angeles, CA
3. Boring CC, Squires TS, Tong T and Montgomery S (1994) Cancer statistics, 1994. CA Cancer J Clin 44: 7-26
4. Breslow NE and Day NE (1980) Statistical Methods in Cancer Research, Vol. I: The Analysis of Case-Control Studies. IARC Scientific Publication 32. IARC: Lyon, France
5. Cohen SM, Hasegawa R, Sakata T and Johansson SL (1989) Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats. Cancer Res 49: 372-377
6. Denda A, Endoh T, Kitayama W, Tang Q, Noguchi O, Kobayashi Y, Akai H, Okajima E, Tsujiuchi T, Tsutsumi M, Nakae D and Konishi Y (1997) Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis 18: 1921-1930
7. Derby LE and Jick H (1996) Acetaminophen and renal and bladder cancer. Epidemiology 7: 358-362
8. DuBois RN, Radhika A, Reddy BS and Entingh AJ (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262
9. Flaks B, Flaks A and Shaw AP (1985) Induction by paracetamol of bladder and liver tumours in the rat. Effects on hepatocyte fine structure. Acta Pathol Microbiol Immunol Scand [A] 93: 367-377
10. Fokkens W (1979) Phenacetin abuse related to bladder cancer. Environ Res 20: 192-198
11. Gago-Dominguez M, Yuan J-M, Castelao JE, Ross RK and Yu MC (1999) Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer 81: 542-548
12. Giardiello FM, Offerhaus GJ and DuBois RN (1995) The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur J Cancer 31A: 1071-1076
13. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC and Speizer FE (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614
14. Grubbs CJ, Juliana MM, Eto I, Casebolt T, Whitaker LM, Canfield GJ, Manczak M, Steele VE and Kelloff GJ (1993) Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors. Anticancer Res 13: 33-36
15. Herschman HR (1994) Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 13: 241-256
16. Hiraga K and Fujii T (1985) Carcinogenicity testing of acetaminophen in F344 rats. Jpn J Cancer Res 76: 79-85
17. Hultengren N, Lagergren C and Ljungqvist A (1965) Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand 130: 314-320
18. Johansson S and Wahlqvist L (1977) Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta Pathol Microbiol Scand [A] 85: 768-774
19. Johansson SL (1981) Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetaminophen). Int J Cancer 27: 521-529
20. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559
21. Kari F, Bucher J, Haseman J, Eustis S and Huff J (1995) Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Jpn J Cancer Res 86: 252-263
22. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R and Sigman CC (1994) Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomarkers Prev 3: 85-98
23. Klän R, Knispel HH and Meier T (1993) Acetylsalicylic acid inhibition of N-butyl-(4-hydroxybutyl) nitrosamine-induced bladder carcinogenesis in rats. J Cancer Res Clin Oncol 119: 482-485
24. Kokmen E, Beard CM, O'Brien PC, Offord KP and Kurland LT (1993) Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology 43: 1887-1892
25. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A and Edwards BK (eds) (1995) SEER Cancer Statistics Review, 1973-1992: Tables and Graphs, National Cancer Institute. NIH Pub. No. 96-2789, Bethesda, MD
26. Kune GA, Kune S and Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48: 4399-4404
27. Liu L, Deapen D, Berstein L and Ross R (1998) Cancer in Los Angeles County: Incidence and Mortality by Race/Ethnicity 1988-1995. Los Angeles County Cancer Surveillance Program, University of Southern California
28. Liu XH and Rose DP (1996) Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 56: 5125-5127
29. Lupulescu A (1996) Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot Essent Fatty Acids 54: 83-94
30. McCredie M and Stewart JH (1988) Does paracetamol cause urothelial cancer or renal papillary necrosis? Nephron 49: 296-300
31. McCredie M, Ford JM, Taylor JS and Stewart JH (1982) Analgesics and cancer of the renal pelvis in New South Wales. Cancer 49: 2617-2625
32. McCredie M Stewart JH, Ford JM and MacLennan RA (1983) Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol 55: 220-224
33. McGeer PL, Schulzer M and McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47: 425-432
34. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
35. Moon RC, Detrisac CJ, Thomas CF and Kelloff GJ (1992) Chemoprevention of experimental bladder cancer. J Cell Biochem Suppl 161: 134-138
36. Moon RC, Kelloff GJ, Detrisac CJ, Steele VE, Thomas CF and Sigman CC (1993) Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam. Carcinogenesis 14: 1487-1489
37. Müller-Decker K, Scholz K, Marks F and Fürstenberger G (1995) Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog 12: 31-41
38. Murai T, Mori S, Machino S, Hosono M, Takeuchi Y, Ohara T, Makino S, Takeda R, Hayashi Y, Iwata H, et al (1993) Induction of renal pelvic carcinoma by phenacetin in hydronephrosis-bearing rats of the SD/cShi strain. Cancer Res 53: 4218-4223
39. Murasaki G, Zenser TV, Davis BB and Cohen SM (1984) Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis. Carcinogenesis 5: 53-55
40. National Center for Health Statistics (1996) Vital Statistics of the United States, 1992: Vol. 2, Mortality, Part A United States Department of Health and Human Services Publication PHS 96-1101. US Dept of Health and Human Services, Public Health Service, CDC: Hyattsville MD
41. Okajima E, Denda A, Ozono S, Takahama M, Akai H, Sasaki Y, Kitayama W, Wakabayashi K and Konishi Y (1998) Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Res 58: 3028-3031
42. O'Neill GP, Mancini JA, Kargman S, Yergey J, Kwan MY, Falgueyret JP, Abramovitz M, Kennedy BP, Ouellet M, Cromlish W, et al (1994) Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol 45: 245-254
43. Piper JM, Tonascia J and Matanoski GM (1985) Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med 313: 292-295
44. Rao KV, Detrisac CJ, Steele VE, Hawk ET, Kelloff GJ and McCormick DL (1996) Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis 17: 1435-1438
45. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P and Härkönen M (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280
46. Shibata MA, Hasegawa R, Shirai T, Takesada Y and Fukushima S (1993) Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model. Int J Cancer 55: 1011-1017
47. Steering Committee of the Physicians' Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 321: 129-135
48. Thun MJ, Namboodiri MM, Calle EE, Flanders WD and Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327
49. Yu MC and Ross RK (1998) Epidemiology of bladder cancer. Carcinoma of the Bladder. Innovations in Management, Petrovich Z, Baert L and Brady LW (eds), pp. 1-13, Springer Verlag: Berlin, Heidelberg
50. Yu MC, Yuan JM and Ross RK (1999) Epidemiology of renal cell carcinoma. In: Carcinoma of the Kidney, Testis and Rare Urologic Malignancies: Innovations in Management, Petrovich Z, Baert L and Brady LW (eds), pp. 3-13. Springer-Verlag: Berlin, Heidelberg